Global Retinal Vein Occlusion Market 2019 Industry Size, Emerging Technologies, Future Demands, Opportunities, Regional Trends and Industry Growth by Forecast 2023
Global “Retinal Vein Occlusion Market” 2019 Research report provides information regarding market size, share, trends, growth, cost structure, key drivers and developments, challenge, opportunity, capacity, revenue and forecast 2023. This report also includes the overall and comprehensive study of the Retinal Vein Occlusion market with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Retinal Vein Occlusion industry and provides data for making strategies to increase the market growth and effectiveness.
Get a sample copy of the report at — https://www.industryresearch.biz/enquiry/request-sample/12459886
Retinal vein occlusion is a retinal vascular disease that mainly affects the older population and causes blindness. The condition is basically of two types, namely, Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO). BRVO is the condition when the blockage occurs in the branch of the retinal vein and blood with fluid spills out into the retina. On the other hand, CRVO is the condition when the blockage occurs in the main retinal vein and blood, and fluid spills out into the retina.
It is noted that the increasing prevalence of diabetes and atherosclerosis, is the key factor driving the retinal vein occlusion market. Various other factors such as the increasing prevalence of glaucoma, lymphoma, and multiple myeloma, and change in lifestyles are also propelling the growth of the market.
The global retinal vein occlusion market is segmented by type, condition, diagnosis, treatment, end-user, and region.
The market for retinal vein occlusion, by type, is segmented into branch retinal artery occlusion and central retinal vein occlusion, in which the branch retinal artery occlusion accounted for the largest market share in 2016. The branch retinal artery occlusion is expected to grow at the fastest CAGR of 11.6% during the forecast period from 20172023.
The retinal vein occlusion market is further segmented, by condition. The condition segment is classified as non-ischemic and ischemic. The non-ischemic segment is projected to grow at the fastest CAGR of 11.6% during the forecast period from 20172023.
The retinal vein occlusion market, by diagnosis, is segmented into Optical Coherence Tomography (OCT), fundoscopic examination, fluorescein angiography, and others. The fundoscopic examination segment is projected to grow at the fastest CAGR of 11.6% during the forecast period from 20172023.
The retinal vein occlusion market, by treatment, is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others. The corticosteroid drugs segment is projected to grow at the fastest CAGR of 11.64% during the forecast period from 20172023.
Enquire before purchasing this report — https://www.industryresearch.biz/enquiry/pre-order-enquiry/12459886
Further, the market is segmented by end-user, which includes hospitals and clinics, research and academics center, and others. Hospitals and clinics accounted for the largest market share in 2016.
By region, the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The European region captured the largest market globally and is expected to reach USD 15,889.59 million by 2023.
Some of the key players in this market are Allergan Plc, Bayer, Bristol-Myers Squibb, Ellex Medical Lasers Ltd., GlaxoSmithKline plc, IRIDEX Corporation, Lumenis, Novartis, NIDEK CO., LTD., Regeneron Pharmaceuticals, F. Hoffmann-La Roche AG, Quantel Medical Inc, Topcon Medical Systems, Inc., and ZEISS.
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of market segments based on type, condition, diagnosis, treatment, end-user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global retinal vein occlusion market
• To provide a detailed analysis of the value chain and supply chain of the global retinal vein occlusion market
• Pharmaceutical and Biotech Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies
• The global retinal vein occlusion market is expected to grow at a rate of 11.2% during the forecast period, 2017 to 2023. The increasing RandD spending, growing healthcare industry, and increased spending on technological advancements are driving the growth of the market
• The branch retinal artery occlusion segment commanded the largest market share in terms of type, in 2016, and is expected to register a CAGR of 11.6% during the forecast period, 20172023
• However, the high cost of treatment and side-effects associated with it may hinder the growth of the market
Purchase this report (Price 4450 USD for a single-user license) — https://www.industryresearch.biz/purchase/12459886
With tables and figures helping analyze worldwide Global Retinal Vein Occlusion market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Key Points from TOC:
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
4.2.1 Increasing prevalence of diabetes and atherosclerosis (Impact Weightage 40%)
4.2.2 Change in lifestyle (Impact Weightage 35%)
4.2.3 Increasing prevalence of glaucoma, lymphoma, and multiple myeloma (Impact Weightage 25%)
4.3.1 Side effect of treatment (Impact Weightage 60%)
4.3.2 High cost of treatment (Impact Weightage 40%)
5 Market Factor Analysis
5.1 Porters Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.3 Distribution and Sales
5.2.4 Post-sales Monitoring
5.3 Demand and Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
6 Global Retinal Vein Occlusion Market, By Type
6.1 Branch Retinal Artery Occlusion
6.2 Central Retinal Vein Occlusion
7 Global Retinal Vein Occlusion Market, By Condition
8 Global Retinal Vein Occlusion Market, By Diagnosis
8.1 Optical Coherence Tomography
8.2 Fundoscopic Examination
8.3 Fluorescein Angiography
9 Global Retinal Vein Occlusion Market, By Treatment
9.1 Antivascular Endothelial Growth Factor
9.2 Corticosteroid Drugs
9.2.1 Triamcinolone Acetonide
9.3 Laser Retinal Photocoagulation
10 Global Retinal Vein Occlusion Market, By End User
10.1 Hospitals and Clinics
10.2 Research and Academics Centers
11 Global Retinal Vein Occlusion Market, By Region
11.3 Asia Pacific
11.4 Middle East and Africa
Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Industry Research is the credible source for gaining the market reports that will provide you with the lead your business needs.
Name: Mr. Ajay More
E-mail: [email protected]
Organization: Industry Research Biz
Phone: US +1424 253 0807 / UK +44 203 239 8187
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Global Retinal Vein Occlusion Market 2019 Industry Size, Emerging Technologies, Future Demands, Opportunities, Regional Trends and Industry Growth by Forecast 2023